To the extent possible under law, the person who associated CC0 with this work has waived all copyright and related or neighboring rights to this work.
DRAVP ID DRAVPa1724
Peptide Name Sequence 49 from Patent US 20100041604
Sequence RRKKAAAAAAAAA
Sequence Length 13
Source Synthetic construct
Target Organism Influenza Virus
Patent Type Patent Application
Publication Date 2010-02-18
Patent No US 2010/0041604 A1
Family Info CA 2727898 A1, WO 2009/152519 A2, US 2010/0041604 A1, WO 2009/152519 A3, EP 2310030 A2, JP 2011524373 A, US 8129499 B2, US 2013/0190228 A1, EP 2310030 A4, US 9221874 B2
Patent Title Novel Antiviral Peptides Against Influenza Virus
Comment 87.5% inhibition against influenza virus at 10 μM.(EC50~7 μM)
Abstract The present disclosure generally relates to peptides having antiviral properties. More particularly, the invention relates to peptides exhibiting activity against influenza viruses, to pharmaceutical compositions comprising the peptides, and to methods of using the peptides to prevent and/or treat influenza viral infections.
To the extent possible under law, the person who associated CC0 with this work has waived all copyright and related or neighboring rights to this work.